Assessment of cardiac autonomic dysfunction in patients with chronic kidney disease using heart rate variability

Devpriya Shukla1, Amit Saxena1, Anju Jha2

  • 1Department of General Medicine, Bundelkhand Medical College, Sagar, Madhya Pradesh, India.

Bioinformation
|October 31, 2025
PubMed

Insights

Heart rate variability (HRV) and baroreflex sensitivity are reduced in chronic kidney disease (CKD) patients, indicating autonomic dysfunction. This non-invasive HRV analysis can help identify early cardiovascular risks in CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Autonomic Neuroscience

Background:

  • Cardiac autonomic dysfunction is a significant complication of chronic kidney disease (CKD).
  • This dysfunction is associated with an elevated risk of cardiovascular events in CKD patients.

Purpose of the Study:

  • To compare heart rate variability (HRV) and baroreflex sensitivity (BRS) between patients with CKD and healthy controls.
  • To investigate the relationship between the severity of CKD and the degree of autonomic dysfunction.

Main Methods:

  • A cross-sectional study involving 120 patients with CKD and 60 healthy individuals.
  • Assessment of HRV parameters and BRS using non-invasive techniques.

Main Results:

  • CKD patients demonstrated significantly impaired HRV parameters and reduced BRS compared to healthy controls (p < 0.001).
  • A correlation was observed where more advanced CKD stages and lower estimated glomerular filtration rate (eGFR) were associated with greater autonomic dysfunction.

Conclusions:

  • Autonomic dysfunction, evidenced by reduced HRV and BRS, is prevalent in CKD patients.
  • Non-invasive HRV analysis serves as a valuable tool for early cardiovascular risk stratification in individuals with CKD.

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
283
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
763
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
516
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
316
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
531
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869